KR101068276B1 - Transparent sunscreen gel and its use - Google Patents
Transparent sunscreen gel and its use Download PDFInfo
- Publication number
- KR101068276B1 KR101068276B1 KR1020087021280A KR20087021280A KR101068276B1 KR 101068276 B1 KR101068276 B1 KR 101068276B1 KR 1020087021280 A KR1020087021280 A KR 1020087021280A KR 20087021280 A KR20087021280 A KR 20087021280A KR 101068276 B1 KR101068276 B1 KR 101068276B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- dimethicone
- trimethicone
- delete delete
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000516 sunscreening agent Substances 0.000 title abstract description 36
- 230000000475 sunscreen effect Effects 0.000 title abstract description 35
- 239000000203 mixture Substances 0.000 claims abstract description 119
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 61
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims abstract description 61
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 61
- 229940008099 dimethicone Drugs 0.000 claims abstract description 60
- 239000003349 gelling agent Substances 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims abstract description 22
- 229920002379 silicone rubber Polymers 0.000 claims abstract description 21
- 125000006267 biphenyl group Chemical group 0.000 claims abstract description 20
- 235000010290 biphenyl Nutrition 0.000 claims abstract description 18
- 239000004305 biphenyl Substances 0.000 claims abstract description 18
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000006096 absorbing agent Substances 0.000 claims abstract description 12
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 9
- 235000011187 glycerol Nutrition 0.000 claims abstract description 6
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000009931 harmful effect Effects 0.000 claims abstract description 4
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 claims abstract description 3
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- -1 phenyl vinyl Chemical group 0.000 claims description 31
- 229920006037 cross link polymer Polymers 0.000 claims description 26
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 14
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 12
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 11
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 10
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 claims description 9
- 229940073663 methyl trimethicone Drugs 0.000 claims description 9
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 229960005193 avobenzone Drugs 0.000 claims description 6
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 6
- 229960004881 homosalate Drugs 0.000 claims description 6
- 229960001679 octinoxate Drugs 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 5
- 229920002554 vinyl polymer Polymers 0.000 claims description 5
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 4
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 2
- 229960000601 octocrylene Drugs 0.000 claims description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical group OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 2
- 229960001173 oxybenzone Drugs 0.000 claims description 2
- 229920002050 silicone resin Polymers 0.000 claims description 2
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 abstract description 16
- NYMPGSQKHIOWIO-UHFFFAOYSA-N hydroxy(diphenyl)silicon Chemical group C=1C=CC=CC=1[Si](O)C1=CC=CC=C1 NYMPGSQKHIOWIO-UHFFFAOYSA-N 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 16
- 239000004359 castor oil Substances 0.000 description 13
- 235000019438 castor oil Nutrition 0.000 description 13
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- 239000002250 absorbent Substances 0.000 description 5
- 230000002745 absorbent Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 3
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000549094 Faex Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229920000572 Nylon 6/12 Polymers 0.000 description 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- WUAIVKFIBCXSJI-UHFFFAOYSA-N butane-1,3-diol;butane-1,4-diol Chemical compound CC(O)CCO.OCCCCO WUAIVKFIBCXSJI-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- ZMUCVNSKULGPQG-UHFFFAOYSA-N dodecanedioic acid;hexane-1,6-diamine Chemical compound NCCCCCCN.OC(=O)CCCCCCCCCCC(O)=O ZMUCVNSKULGPQG-UHFFFAOYSA-N 0.000 description 2
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229960003951 masoprocol Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 2
- 230000036561 sun exposure Effects 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- VVDFMBJYUNNCPO-MQWKRIRWSA-N (2s)-6-amino-2-(2,3-dihydroxypropylamino)hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NCC(O)CO VVDFMBJYUNNCPO-MQWKRIRWSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- DZOOROWXIIPFGA-UHFFFAOYSA-N 2-hydroxypropyl heptanoate Chemical compound CCCCCCC(=O)OCC(C)O DZOOROWXIIPFGA-UHFFFAOYSA-N 0.000 description 1
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- PVTDNWCFSNHEJD-UHFFFAOYSA-N Amentoflavon Natural products COc1ccc(cc1)C2=CC(=O)c3c(OC)cc(OC)c(c3O2)c4ccc(OC)c(c4)C5=CC(=O)c6c(OC)cc(OC)cc6O5 PVTDNWCFSNHEJD-UHFFFAOYSA-N 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 239000004358 Butane-1, 3-diol Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- 241000195974 Selaginella Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HITDPRAEYNISJU-UHFFFAOYSA-N amenthoflavone Natural products Oc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HITDPRAEYNISJU-UHFFFAOYSA-N 0.000 description 1
- YUSWMAULDXZHPY-UHFFFAOYSA-N amentoflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 YUSWMAULDXZHPY-UHFFFAOYSA-N 0.000 description 1
- HVSKSWBOHPRSBD-UHFFFAOYSA-N amentoflavone Natural products Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HVSKSWBOHPRSBD-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 229960002380 dibutyl phthalate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OXGBCSQEKCRCHN-UHFFFAOYSA-N octadecan-2-ol Chemical compound CCCCCCCCCCCCCCCCC(C)O OXGBCSQEKCRCHN-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- NQJGJBLOXXIGHL-UHFFFAOYSA-N podocarpusflavone A Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O NQJGJBLOXXIGHL-UHFFFAOYSA-N 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 229940116350 propylene glycol heptanoate Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical class [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 1종 이상의 화학적 자외선(UV) 흡수제, 1종 이상의 용매 및 1종 이상의 디페닐 실리콘 엘라스토머 겔화제를 함유하는 무알콜 투명한 태양광 차단 조성물에 관한 것이다. 바람직하게는, 용매가 디메티콘, 디카프릴릴 카르보네이트, 라우릴 락테이트, 네오펜틸 글리콜 디헵타노에이트, 글리세린 및 이들의 조합으로 이루어진 군으로부터 선택되고, 디페닐 실리콘 엘라스토머 겔화제는 디페닐실록시 페닐 트리메티콘을 함유한다. 이러한 투명한 태양광 차단 조성물은 자외선의 유해한 영향으로부터 피부를 보호하기 위한, 안정하고 미적으로 선호되는 투명 겔을 형성하는데 사용될 수 있다.The present invention relates to an alcohol-free transparent sunscreen composition containing at least one chemical ultraviolet (UV) absorber, at least one solvent and at least one diphenyl silicone elastomer gelling agent. Preferably, the solvent is selected from the group consisting of dimethicone, dicaprylyl carbonate, lauryl lactate, neopentyl glycol diheptanoate, glycerin and combinations thereof, and the diphenyl silicone elastomer gelling agent is diphenylsiloxane Cyphenyl trimethicone. Such transparent sunscreen compositions can be used to form stable and aesthetically preferred transparent gels for protecting the skin from the harmful effects of ultraviolet radiation.
자외선 흡수제, 태양광 차단제, 겔화제, 디페닐 실리콘UV absorbers, sunscreens, gelling agents, diphenyl silicone
Description
본 발명은 피부 보호 화장용 조성물 및 그의 사용 방법에 관한 것이다. 특히, 본 발명은 신규한 투명 무알콜 태양광 차단 겔 및 그의 사용 방법에 관한 것이다.The present invention relates to a skin care cosmetic composition and a method of using the same. In particular, the present invention relates to novel transparent alcohol-free sunscreen gels and methods of use thereof.
태양광에 대한 노출의 부작용은 잘 알려져 있다. 예를 들어, 피부가 약 290 nm 내지 약 400 nm 파장의 자외선에 노출된 경우, 태양광에 지속적으로 노출되게 되면 일광 화상 및 피부의 조기 노화와 같은 단기 손상이 유발될 수 있다. 또한, 장기 손상은 피부암과 같은 심각한 질병을 일으킬 수 있다. 과도한 태양광 노출로 인한 이러한 건강상의 위험 때문에, 태양광 차단 제품들이 계속 요구된다. 따라서, 태양광 차단제를 포함한 매일 사용하는 제품을 비롯한 다양한 태양광 차단 제품이 시판되고 있다. 이러한 태양광 차단 제품의 사용이 증가됨에 따라, 소비자들은 태양 광선을 효과적으로 차단할 뿐만 아니라, 피부에 도포시 미적으로도 만족스러운 태양광 차단 제품의 개발을 요구한다.The side effects of exposure to sunlight are well known. For example, when the skin is exposed to ultraviolet light at wavelengths of about 290 nm to about 400 nm, constant exposure to sunlight can cause short-term damage such as sunburn and premature aging of the skin. In addition, organ damage can cause serious diseases such as skin cancer. Because of this health risk due to excessive sun exposure, sunscreen products continue to be required. Therefore, various sunscreen products are commercially available, including daily use products including sunscreen agents. As the use of such sunscreen products increases, consumers are required to develop sunscreen products that not only effectively block the sun's rays, but are also aesthetically pleasing when applied to the skin.
투명 화장용 조성물은 보통 땀억제제 및 모발 겔에서 사용된다. 이러한 조성물은 전형적으로 투명한 에멀젼(다르게는 겔로 알려짐)에 일치하는 굴절률을 갖 는 폴리올 및 실리콘 유화제를 포함한다. 그러나, 기존의 투명 태양광 차단제에서는, 일반적으로 사용되는 실리콘 엘라스토머가 태양광 차단 성분을 충분히 증점시키지 못해서, 추가적인 왁스가 필요하다. 불행히도, 추가적인 왁스는 기존의 투명 태양광 차단 조성물의 투명도를 떨어뜨리고, 종종 조성물을 너무 증점시키게 되므로 소비자가 선호하지 않는다. 또한, 기존의 태양광 차단 조성물은 전형적으로 알콜을 함유하는데, 이는 태양광 차단 제품을 피부에 도포시에 염증을 일으키고 피부를 건조하게 만들 수 있다.Transparent cosmetic compositions are commonly used in sweat inhibitors and hair gels. Such compositions typically include polyols and silicone emulsifiers that have a refractive index consistent with a clear emulsion (also known as a gel). However, in conventional transparent sunscreens, silicone elastomers that are commonly used do not thicken the sunscreen components sufficiently, so additional wax is needed. Unfortunately, additional waxes do not favor the consumer because they degrade the transparency of existing transparent sunscreen compositions and often cause the compositions to thicken too much. In addition, existing sunscreen compositions typically contain alcohols, which can cause inflammation and dry skin when applying sunscreen products to the skin.
따라서, 충분한 농도를 가지면서 동시에 원하는 투명도를 유지하고 소비자가 미적으로 선호하는 향상된 투명 태양광 차단 겔 조성물이 요구된다. 또한, 본질적으로 알콜을 함유하지 않아서 피부에 염증을 일으키지 않는 향상된 투명 태양광 차단 겔 조성물이 요구된다.Therefore, there is a need for an improved clear sunscreen gel composition that has sufficient concentration and at the same time maintains the desired transparency and is aesthetically preferred by the consumer. There is also a need for an improved clear sunscreen gel composition that is essentially free of alcohol and thus does not irritate the skin.
발명의 요약Summary of the Invention
본 발명은 한 측면에서, 투명하고 본질적으로 알콜을 함유하지 않으며, 1종 이상의 화학적 자외선(UV) 흡수제, 1종 이상의 용매 및 1종 이상의 디페닐 실리콘 엘라스토머 겔화제(gellant)를 포함하는 화장용 조성물에 관한 것이다. The present invention, in one aspect, is transparent and essentially free of alcohol and comprises a cosmetic composition comprising at least one chemical ultraviolet (UV) absorber, at least one solvent and at least one diphenyl silicone elastomer gelling agent. It is about.
본원에서 사용되는 용어 "투명한"은 그 주변의 굴절률(RI)과 일치하는 RI를 갖는 조성물 또는 물질(즉, 이러한 조성물 또는 물질은 그의 기능성 환경 내에서 기능성 환경에 대하여 투명함)을 나타낸다. 바람직하게는, 본 발명에서 설명되는 투명한 조성물 또는 물질은 약 70% 초과, 더욱 바람직하게는 약 75% 초과의 광투과율을 나타내며, 광산란 특성을 전혀 나타내지 않는다.As used herein, the term “transparent” refers to a composition or material having an RI that matches its refractive index (RI) (ie, such a composition or material is transparent to the functional environment within its functional environment). Preferably, the transparent composition or material described herein exhibits a light transmittance of greater than about 70%, more preferably greater than about 75%, and exhibits no light scattering properties.
본원에서 사용되는 용어 "본질적으로 알콜을 함유하지 않는"은 조성물 또는 물질의 총 중량을 기준으로 약 0.5% 미만의 에틸 알콜 함량을 갖는 조성물 또는 물질을 나타낸다.As used herein, the term "essentially free of alcohol" refers to a composition or material having an ethyl alcohol content of less than about 0.5% based on the total weight of the composition or material.
다른 측면에서, 본 발명은 상기 투명한 화장용 조성물을 피부에 도포함으로써 자외선의 유해한 영향으로부터 피부를 보호하기 위한, 상기 기재한 투명한 화장용 조성물의 사용 방법에 관한 것이다.In another aspect, the present invention relates to a method of using the above-mentioned transparent cosmetic composition for protecting the skin from the harmful effects of ultraviolet rays by applying the transparent cosmetic composition to the skin.
본 발명의 다른 측면 및 목적은 하기의 기재, 실시예 및 청구의 범위에 의하여 더욱 확실해질 것이다.Other aspects and objects of the invention will be further clarified by the following description, examples and claims.
실시예 및 비교예, 또는 달리 명시적으로 언급한 경우를 제외하고는, 본원에 기재된 물질의 양 또는 비율, 또는 반응 조건, 물질의 물리적 성질 및/또는 용도를 나타내는 모든 숫자는 단어 "약"으로 수식된 것으로 이해되어야 한다. 달리 언급되지 않는 한, 모든 양은 최종 조성물의 중량을 기준으로 한다. Except in the Examples and Comparative Examples, or where expressly stated otherwise, all numbers indicating the amount or ratio of a substance described herein, or reaction conditions, physical properties and / or uses of the substance are the words "about". It should be understood as being modified. Unless stated otherwise, all amounts are based on the weight of the final composition.
본 발명에서, 놀랍게도 특정 디페닐 실리콘 엘라스토머 겔화제와 1종 이상의 특정 비알콜 용매(들)를 화학적 자외선 흡수제와 조합함으로써, 미적으로 선호되는 투명 태양광 차단 겔로서 특히 유용한, 안정하고 무알콜이며 투명한 화장용 조성물을 형성할 수 있다는 것이 밝혀졌다. 본원에서 사용되는 용어 "안정한"은 충분한 물리적 및 화학적 안정성을 가져서 모든 성분들이 첨가되었을 때 분리되거나 침전되지 않는 조성물을 나타낸다. 본원에서 사용되는 용어 "미적으로 선호되는"은 피부에 도포시, 파우더, 벨벳 및 실크 감촉을 나타내는 조성물을 나타낸다. In the present invention, a stable, non-alcoholic and transparent makeup which is surprisingly useful as aesthetically preferred transparent sunscreen gels, by surprisingly combining certain diphenyl silicone elastomer gelling agents and one or more specific non-alcohol solvent (s) with chemical ultraviolet absorbers. It has been found that the composition can be formed. As used herein, the term “stable” refers to a composition that has sufficient physical and chemical stability so that all components are not separated or precipitated when added. As used herein, the term “aesthetically preferred” refers to a composition that, when applied to the skin, exhibits a powder, velvet and silky feel.
본 발명의 투명한 화장용 조성물의 첫 번째 필수 성분으로서, 화학적 자외선 흡수제가 사용된다. 화학적 자외선 흡수제는 화장용 조성물에 보통 사용되는 임의의 적합한 화학적 자외선 흡수제일 수 있다. 적합한 화학적 자외선 흡수제의 특정 예로는, 이에 제한되는 것은 아니지만, 벤조페논-3, 호모살레이트, 에틸헥실 메톡시신나메이트, 아보벤존, 에틸헥실 살리실레이트 및 옥토크릴렌 및 이들의 조합을 들 수 있다. 바람직하게는, 본 발명의 투명한 화장용 조성물 내에서 화학적 자외선 흡수제는 조성물의 총 중량을 기준으로 약 1% 내지 약 20%, 더욱 바람직하게는 약 2% 내지 약 15%의 양으로 존재한다. 특히, 본 발명의 투명한 화장용 조성물은 조성물의 투명도를 떨어뜨리는 것으로 알려진 산화티타늄 및 산화아연과 같은 물리적 UV 흡수제를 전혀 포함하지 않는다.As the first essential ingredient of the transparent cosmetic composition of the present invention, a chemical ultraviolet absorber is used. The chemical ultraviolet absorbent can be any suitable chemical ultraviolet absorbent commonly used in cosmetic compositions. Specific examples of suitable chemical ultraviolet absorbers include, but are not limited to, benzophenone-3, homosalate, ethylhexyl methoxycinnamate, avobenzone, ethylhexyl salicylate and octocrylene and combinations thereof. have. Preferably, the chemical ultraviolet absorbent in the transparent cosmetic composition of the present invention is present in an amount from about 1% to about 20%, more preferably from about 2% to about 15%, based on the total weight of the composition. In particular, the transparent cosmetic composition of the present invention does not contain any physical UV absorbers such as titanium oxide and zinc oxide, which are known to reduce the transparency of the composition.
본 발명의 투명한 화장용 조성물의 두 번째 필수 성분으로서, 1종 이상의 용매계가 사용된다. 용매계는 화학적 자외선 흡수제를 용해시키고 담지하기에 적합한 임의의 용매 또는 용매들을 포함할 수 있다. 적합한 용매의 특정 예로는, 이에 제한되는 것은 아니지만, 디메티콘 (예컨대, DM-플루이드 A-6CS (신에쯔 케미칼(Shin-Etsu Chemical Co., Ltd., 도꾜, 일본)로부터 구입 가능)), 디카프릴릴 카르보네이트 (예컨대, 세티올(cetiol)® CC (코그니스 코포레이션(Cognis Corporation, 신시네티, 오하이오)로부터 구입 가능), 라우릴 락테이트 (예컨대, 세라필(ceraphyl)® 31 (인터내셔널 스페셜티 프로덕츠(International Specialty Products, 웨인, 뉴저지)로부터 구입 가능), 네오펜틸 글리콜 디헵타노에이트 (예컨대, 렉스필(Lexfeel)® 7 (이놀렉스 케미칼 (Inolex Chemical Co., 필라델피아, 펜실베니아)로부터 구입 가능), 글리세린 및 이들의 조합을 들 수 있다. 바람직하게는, 반드시 필요한 것은 아니지만, 본 발명의 조성물은 특히 상기 기재한 화학적 자외선 흡수제와 상용성인 디메티콘과 같은 실리콘-기재 용매를 포함한다. 용매(들)은 조성물의 총 중량을 기준으로 약 1% 내지 약 30%, 바람직하게는 약 10% 내지 약 29%, 가장 바람직하게는 약 15% 내지 약 28%의 양으로 존재한다.As a second essential ingredient of the transparent cosmetic composition of the present invention, at least one solvent system is used. The solvent system may include any solvent or solvents suitable for dissolving and supporting the chemical ultraviolet absorbent. Specific examples of suitable solvents include, but are not limited to, dimethicone (eg, DM-fluid A-6CS (available from Shin-Etsu Chemical Co., Ltd., Tokyo, Japan)), Dicaprylyl carbonate (e.g., cetiol® CC (commercially available from Cognis Corporation, Cincinnati, Ohio)), lauryl lactate (e.g., ceraphyl® 31 (international specialty) Products (available from International Specialty Products, Wayne, NJ), neopentyl glycol diheptanoate (e.g., Lexfeel® 7 (available from Inolex Chemical Co., Philadelphia, Pennsylvania)), Glycerin and combinations thereof, preferably, but not necessarily, the compositions of the present invention are particularly suitable for the use of silicones such as dimethicone that are compatible with the above-described chemical UV absorbers. The solvent (s) may comprise from about 1% to about 30%, preferably from about 10% to about 29%, most preferably from about 15% to about 28%, based on the total weight of the composition. Present in quantities.
화학적 자외선 흡수제는 대부분 투명도가 낮은 분말 형태라는 것이 알려져 있다. 기존의 태양광 차단 조성물에서는 이러한 화학적 자외선 흡수제의 용해도를 높이기 위하여 많은 양의 에틸 알콜이 사용되어 왔다. 그러나, 에틸 알콜 함량이 높은 태양광 차단 조성물은 일반적으로 조성물을 피부에 도포시에 염증을 일으킨다. 본 발명에서는, 놀랍게도 화학적 자외선 흡수제의 용해도를 효과적으로 증가시키기 위하여, 에틸 알콜을 사용하지 않고, 세 번째 필수 성분, 즉, 디페닐 실리콘 엘라스토머 겔화제, 더욱 구체적으로는, 디페닐실록시 페닐 트리메티콘을 포함하는 디페닐 실리콘 엘라스토머 겔화제를 사용할 수 있다는 것이 밝혀졌다. 임의의 이론에 구속되려는 것은 아니지만, 실리콘 엘라스토머 겔화제의 디페닐기가 UV 흡수제의 디페닐기와 상호작용을 하여, 조성물 중 UV 흡수제의 용해도를 증가시키는 것으로 생각된다. 본 발명의 태양광 차단 조성물 중 디페닐실록시 페닐 트리메티콘의 총량은 조성물의 종량을 기준으로 약 1% 내지 약 50%일 수 있다. It is known that chemical ultraviolet absorbers are mostly in powder form with low transparency. In existing sunscreen compositions, large amounts of ethyl alcohol have been used to increase the solubility of such chemical ultraviolet absorbers. However, sunscreen compositions with a high ethyl alcohol content generally cause inflammation when the composition is applied to the skin. In the present invention, surprisingly, in order to effectively increase the solubility of the chemical ultraviolet absorbent, without using ethyl alcohol, a third essential ingredient, namely diphenyl silicone elastomer gelling agent, more specifically diphenylsiloxy phenyl trimethicone It has been found that diphenyl silicone elastomer gelling agents can be used. Without wishing to be bound by any theory, it is believed that the diphenyl group of the silicone elastomer gelling agent interacts with the diphenyl group of the UV absorber, thereby increasing the solubility of the UV absorber in the composition. The total amount of diphenylsiloxy phenyl trimethicone in the sunscreen composition of the present invention may be from about 1% to about 50% based on the amount of the composition.
본 발명의 한 특정 실시태양에서, 디페닐 실리콘 엘라스토머 겔화제는 디페닐실록시 페닐 트리메티콘 및 디메티콘/페닐 비닐 디메티콘 교차중합체(crosspolymer)의 혼합물을 포함한다. 바람직하게는, 이러한 혼합물은 혼합물의 총 중량을 기준으로, 디페닐실록시 페닐 트리메티콘 약 80% 내지 약 90% 및 디메티콘/페닐 비닐 디메티콘 교차중합체 약 10% 내지 약 20%를 포함한다. 예를 들어, 디페닐실록시 페닐 트리메티콘 85 중량% 및 디메티콘/페닐 비닐 디메티콘 교차중합체 약 15 중량%를 포함하는 혼합물인 KSG-18A (신에쯔 케미칼(도꾜, 일본)로부터 구입 가능)가 본 발명의 조성물에서 디페닐 실리콘 엘라스토머 겔화제로 사용된다. KSG-18A가 본 발명의 조성물에서 겔화제로 사용되는 경우, 각 조성물의 총 중량을 기준으로 35% 내지 약 55%, 더욱 바람직하게는 약 40% 내지 약 50%, 가장 바람직하게는 약 44% 내지 약 46%의 양으로 존재할 수 있다.In one particular embodiment of the invention, the diphenyl silicone elastomer gelling agent comprises a mixture of diphenylsiloxy phenyl trimethicone and dimethicone / phenyl vinyl dimethicone crosspolymer. Preferably such mixtures comprise from about 80% to about 90% of diphenylsiloxy phenyl trimethicone and from about 10% to about 20% of dimethicone / phenyl vinyl dimethicone crosspolymer, based on the total weight of the mixture . For example, KSG-18A (commercially available from Shin-Etsu Chemical, Japan), which is a mixture comprising 85% by weight of diphenylsiloxy phenyl trimethicone and about 15% by weight of dimethicone / phenyl vinyl dimethicone crosspolymer. ) Is used as diphenyl silicone elastomer gelling agent in the composition of the present invention. When KSG-18A is used as a gelling agent in the compositions of the present invention, from 35% to about 55%, more preferably from about 40% to about 50%, most preferably from about 44% to about the total weight of each composition It may be present in an amount of about 46%.
본 발명의 또다른 특정 실시태양에서, 디페닐 실리콘 엘라스토머 겔화제는 디페닐실록시 페닐 트리메티콘, 디메티콘/페닐 비닐 디메티콘 교차중합체 및 메틸 트리메티콘의 혼합물을 포함한다. 바람직하게는, 이러한 혼합물은 혼합물의 총 중량을 기준으로, 디페닐실록시 페닐 트리메티콘 약 10% 내지 약 15%, 디메티콘/페닐 비닐 디메티콘 교차중합체 약 25% 내지 약 35%, 및 메틸 트리메티콘 약 55% 내지 약 60%를 포함한다. 예를 들어, 디페닐실록시 페닐 트리메티콘 약 13 중량%, 디메티콘/페닐 비닐 디메티콘 교차중합체 약 30 중량%, 및 메틸 트리메티콘 약 57 중량%를 포함하는 혼합물인 X-21-5652D (신에쯔 케미칼(도꾜, 일본)로부터 구입 가능)가 본 발명의 조성물에서 디페닐 실리콘 엘라스토머 겔화제로 사용된다. X-21-5652D가 본 발명의 조성물에서 겔화제로 사용되는 경우, 조성물의 총 중량을 기준으로 약 5% 내지 약 25%, 더욱 바람직하게는 약 7% 내지 약 20%, 및 가장 바람직하게는 약 10% 내지 약 17%의 양으로 존재할 수 있다.In another particular embodiment of the invention, the diphenyl silicone elastomer gelling agent comprises a mixture of diphenylsiloxy phenyl trimethicone, dimethicone / phenyl vinyl dimethicone crosspolymer and methyl trimethicone. Preferably such mixtures comprise from about 10% to about 15% of diphenylsiloxy phenyl trimethicone, from about 25% to about 35% of dimethicone / phenyl vinyl dimethicone crosspolymer, and methyl based on the total weight of the mixture Trimethicone from about 55% to about 60%. For example, X-21-5652D is a mixture comprising about 13 weight percent diphenylsiloxy phenyl trimethicone, about 30 weight percent dimethicone / phenyl vinyl dimethicone crosspolymer, and about 57 weight percent methyl trimethicone (Commercially available from Shin-Etsu Chemical (Tokyo, Japan)) is used as diphenyl silicone elastomer gelling agent in the composition of the present invention. When X-21-5652D is used as a gelling agent in a composition of the present invention, from about 5% to about 25%, more preferably from about 7% to about 20%, and most preferably about about the total weight of the composition It may be present in an amount of 10% to about 17%.
본 발명의 또다른 실시태양에서, 디페닐 실리콘 엘라스토머 겔화제는 상기 기재한 디페닐실록시 페닐 트리메티콘 및 디메티콘/페닐 비닐 디메티콘 교차중합체의 첫 번째 혼합물 (예를 들어, KSG- 18A), 및 디페닐실록시 페닐 트리메티콘, 디메티콘/페닐 비닐 디메티콘 교차중합체 및 메틸 트리메티콘의 두 번째 혼합물 (예를 들어, X-21-5652D)을 포함할 수 있다.In another embodiment of the invention, the diphenyl silicone elastomer gelling agent is the first mixture of diphenylsiloxy phenyl trimethicone and dimethicone / phenyl vinyl dimethicone crosspolymers described above (eg, KSG-18A). And a second mixture of diphenylsiloxy phenyl trimethicone, dimethicone / phenyl vinyl dimethicone crosspolymer and methyl trimethicone (eg, X-21-5652D).
본 발명의 투명한 화장용 조성물의 감촉을 추가로 향상시키기 위하여, 실리콘 고무 코어가 실리콘 수지 쉘로 코팅된 혼성 실리콘 분말을 임의로 상기 조성물에 첨가할 수 있다. 본 발명에 사용하기 적합한 혼성 실리콘 분말의 특정 예로는, 이에 한정되는 것은 아니지만, 비닐 디메티콘/메티콘 실세스퀴옥산 교차중합체를 포함하는 KSP-100 분말 (신에쯔 케미칼(도꾜, 일본)로부터 구입 가능)을 들 수 있다. KSP-100 혼성 실리콘 분말은 독특하게 부드러운 실크 느낌을 제공하고, 양호한 분산성/퍼짐성을 가지며, 응집이 적다. KSP-1OO이 본 발명의 조성물에서 사용되는 경우, 조성물의 총 중량을 기준으로 약 0.5% 내지 약 10%, 더욱 바람직하게는 약 1% 내지 약 5%의 양으로 존재할 수 있다.In order to further enhance the feel of the transparent cosmetic composition of the present invention, a hybrid silicone powder coated with a silicone resin shell with a silicone rubber core may optionally be added to the composition. Specific examples of hybrid silicone powders suitable for use in the present invention include, but are not limited to, KSP-100 powders (Shin-Etsu Chemical (Tokyo, Japan)) including vinyl dimethicone / methicone silsesquioxane crosspolymers. Available for purchase). KSP-100 hybrid silicone powder provides a uniquely smooth silky feel, has good dispersibility / spreadability and low aggregation. When KSP-1OO is used in the compositions of the present invention, it may be present in an amount of about 0.5% to about 10%, more preferably about 1% to about 5%, based on the total weight of the composition.
또한, 본 발명의 투명한 화장용 조성물은 임의로는 투명도 및 소비자의 미적 선호도에 악영향을 미치지 않으면서 조성물의 점도를 증가시키기 위한 증점제를 포함할 수 있다. 바람직하게는, 증점제는 디메티콘/페닐 비닐 디메티콘 교차중합체를 포함한다. 더욱 바람직하게는, 증점제는 KSG-18 실리콘 페이스트 (신에쯔 케미칼(도꾜, 일본)로부터 구입 가능)와 같은 디메티콘/페닐 비닐 디메티콘 교차중합체와 페닐 트리메티콘의 혼합물을 포함한다. KSG-18이 본 발명의 조성물에서 겔화제로 사용되는 경우, 각 조성물의 총 중량을 기준으로 35% 내지 약 55%, 더욱 바람직하게는 약 40% 내지 약 50%, 가장 바람직하게는 약 44% 내지 약 46%의 양으로 존재할 수 있다.In addition, the transparent cosmetic composition of the present invention may optionally include a thickening agent for increasing the viscosity of the composition without adversely affecting the transparency and aesthetic preference of the consumer. Preferably, the thickener comprises dimethicone / phenyl vinyl dimethicone crosspolymer. More preferably, the thickener comprises a mixture of dimethicone / phenyl vinyl dimethicone crosspolymers and phenyl trimethicone, such as KSG-18 silicone paste (commercially available from Shin-Etsu Chemical (Tokyo, Japan)). When KSG-18 is used as the gelling agent in the compositions of the present invention, 35% to about 55%, more preferably about 40% to about 50%, most preferably about 44% to about the total weight of each composition It may be present in an amount of about 46%.
상기 기재한 본 발명의 투명한 화장용 조성물은 바람직하게는 무수 (즉, 조성물의 총 중량을 기준으로 약 0.5% 미만의 물을 함유) 및 무알콜 (즉, 조성물의 총 중량을 기준으로 약 0.5% 미만의 에틸 알콜을 함유)이다. 더욱 바람직하게는, 본 발명의 조성물은 겔 에멀젼의 형태이고, 16,000 cps 내지 28,000 cps의 점도를 갖는다.The transparent cosmetic compositions of the invention described above are preferably anhydrous (ie, containing less than about 0.5% water based on the total weight of the composition) and alcohol-free (ie, less than about 0.5% based on the total weight of the composition). Containing ethyl alcohol). More preferably, the composition of the present invention is in the form of a gel emulsion and has a viscosity of 16,000 cps to 28,000 cps.
필요에 따라, 투명도 및 점도가 저하되지 않는 한, 본 발명의 조성물에 다른 생물학적 활성제가 첨가될 수 있다. 통상적인 실험을 통하여 안정한 조성물을 유지하기 위해 필요한 양을 결정할 수 있다. 국소 화장용 또는 제약 조성물에서 유리하게 사용되는 임의의 유형의 생물학적 활성제가 첨가될 수 있다. 예를 들어, 조성물은 추가로 보습 활성제, 노화성 반점, 각화증 및 주름의 치료제, 또한, 진통제, 마취제, 항여드름제, 항균제, 항효모제, 항진균제, 항바이러스제, 비듬 방지제, 피부염 방지제, 소양증 방지제, 제토제, 동요병 방지제, 항자극제, 소염제, 항각화과다제, 항건조피부제, 항건선제, 항지루제, 노화 방지제, 주름 방지제, 추가적인 태양광 차단제, 항히스타민제, 피부 미백제, 탈색제, 창상 치유제, 비타민, 코르티코스테로이드, 자기-탄닝제(self-tanning agent), 또는 호르몬을 포함할 수 있다. 상기 기재한 생물학적 활성제는 본 발명의 태양광 차단 조성물의 단지 임의 성분에 해당하는 것이며, 조성물의 태양광 차단 기능에 실질적인 영향을 주지 않고 조성물로부터 생략될 수 있다. If desired, other biologically active agents may be added to the compositions of the present invention, as long as the transparency and viscosity do not decrease. Routine experimentation may determine the amount required to maintain a stable composition. Any type of biologically active agent which is advantageously used in topical cosmetic or pharmaceutical compositions can be added. For example, the composition may further comprise a moisturizing active agent, an agent for aging spots, keratosis and wrinkles, as well as analgesics, anesthetics, antiacne, antibacterial agents, anti yeasts, antifungal agents, antiviral agents, antidandruff agents, dermatitis inhibitors, antipruritic agents. Antiseptics, anti-irritants, anti-inflammatory agents, anti-keratogenic agents, anti-dry skin, anti-psoriasis, anti-seborrheic agents, anti-aging agents, anti-wrinkle agents, additional sunscreen, antihistamines, skin whitening agents, bleaching agents, wounds Healing agents, vitamins, corticosteroids, self-tanning agents, or hormones. The biologically active agents described above correspond to only any of the components of the sunscreen composition of the present invention and may be omitted from the composition without substantially affecting the sunscreen function of the composition.
본 출원의 태양광 차단 조성물은, 투명도 및 점도를 저하시키지 않는 한에서, 추가로 화장제용으로 허용가능한 비히클을 포함한다. 본 출원의 태양광 차단 조성물 내로 배합될 수 있는 물질은, 이에 한정되는 것은 아니지만, 보습제, 수렴제, 킬레이팅제, 계면활성제, 유연제, 방부제, 안정제, 습윤제, 방향제 등이 있다. 바람직하게는, 반드시 필요한 것은 아니지만, 이러한 비히클은 피부상에 보호층을 형성하는 것을 돕는다. 비히클 또는 비히클들은 본 발명의 국소 조성물에서, 국소 조성물의 총 중량을 기준으로 약 1% 내지 약 99.9%, 바람직하게는 약 50% 내지 약 99.5%, 더욱 바람직하게는 약 70% 내지 약 99%, 가장 바람직하게는 약 80% 내지 90%의 양으로 존재할 수 있다. The sunscreen composition of the present application further includes an acceptable vehicle for cosmetics, so long as the transparency and viscosity are not reduced. Materials that can be blended into the sunscreen composition of the present application include, but are not limited to, moisturizers, astringents, chelating agents, surfactants, softeners, preservatives, stabilizers, wetting agents, fragrances and the like. Preferably, but not necessarily, such vehicles help to form a protective layer on the skin. Vehicle or vehicles are, in the topical compositions of the present invention, from about 1% to about 99.9%, preferably from about 50% to about 99.5%, more preferably from about 70% to about 99%, based on the total weight of the topical composition, Most preferably, in an amount of about 80% to 90%.
예를 들어, 본 발명의 태양광 차단 조성물에서 사용될 수 있는 유연제는, 이에 한정되는 것은 아니지만, 스테아릴 알콜, 세틸 알콜, 올레일 알콜, 이소세틸 알콜, 지방 알콜, 프로판-1,2-디올, 부탄-1,3-디올, 옥타데칸-2-올, 글리세릴 모노스테아레이트, 이소프로필 이소스테아레이트, 스테아르산, 이소스테아르산, 이소세틸 스테아레이트, 이소프로필 스테아레이트, 부틸 스테아레이트, 이소프로필 라우레이트, 헥실 라우레이트, 데실 올레에이트, 이소부틸 팔미테이트, 세틸 팔미테이트, 이소프로필 팔미테이트, 팔미트산, 디메틸폴리실록산, 글리세릴 모노리신올레에이트, 디-n-부틸 세바케이트, 이소프로필 미리스테이트, 부틸 미리스테이트, 미리스틸 미리스테이트, 이소프로필 리놀레에이트, 라우릴 락테이트, 미리스틸 락테이트, 폴리에틸렌 글리콜, 트리에틸렌 글리콜, 트리에틸렌린, 아세틸레이티화 라놀린, 참기름, 코코넛유, 아라키스유, 피마자유, 밍크유, 광유 및 석유를 포함한다. For example, softeners that may be used in the sunscreen compositions of the invention include, but are not limited to, stearyl alcohol, cetyl alcohol, oleyl alcohol, isocetyl alcohol, fatty alcohol, propane-1,2-diol, Butane-1,3-diol, octadecane-2-ol, glyceryl monostearate, isopropyl isostearate, stearic acid, isostearic acid, isocetyl stearate, isopropyl stearate, butyl stearate, isopropyl Laurate, hexyl laurate, decyl oleate, isobutyl palmitate, cetyl palmitate, isopropyl palmitate, palmitic acid, dimethylpolysiloxane, glyceryl monolysine oleate, di-n-butyl sebacate, isopropyl myri State, butyl myristate, myristyl myristate, isopropyl linoleate, lauryl lactate, myristyl lactate, polyethylene glycol, Glycol, triethylene Lin, acetyl ray tihwa include lanolin, sesame oil, coconut oil, arachis oil, castor oil, mink oil, mineral oil and petroleum.
또한 저장 기간을 연장시키기 위하여 본 발명의 태양광 차단 조성물에 다양한 방부제를 첨가할 수 있다. 적합한 방부제는, 이에 한정되는 것은 아니지만, 칼륨 소르베이트, 이미다졸리디닐 우레아, p-히드록시 벤조에이트, p-히드록시벤조산의 에스테르, CTFA 명칭 파라벤, 에틸헥실글리세린, 카르릴릴 글리콜/페녹시에탄올/헥실렌 글리콜 등이 있다. 본 발명의 태양광 차단 조성물에 사용하기 적합한 다른 방부제는 문헌 [International Cosmetic Ingredient Dictionary and Handbook, 제20판, 2004]에 개시되어 있으며, 이 문헌은 전체로서 본원에 참고 문헌으로 도입된다.In addition, various preservatives may be added to the sunscreen composition of the present invention to extend the shelf life. Suitable preservatives include, but are not limited to, potassium sorbate, imidazolidinyl urea, p-hydroxy benzoate, esters of p-hydroxybenzoic acid, CTFA name paraben, ethylhexylglycerine, carrylyl glycol / phenoxyethanol / Hexylene glycol and the like. Other preservatives suitable for use in the sunscreen compositions of the present invention are disclosed in the International Cosmetic Ingredient Dictionary and Handbook, 20th Edition, 2004, which is incorporated herein by reference in its entirety.
사용될 수 있는 습윤제는, 이에 한정되는 것은 아니지만, 다가 알콜, 예컨대, 글리세롤, 폴리알킬렌 글리콜, 및 알킬렌 폴리올 및 이들의 혼합물, 하이알루론산, 우레아, 글리세린, 소르비톨, 나트륨 2-피롤리돈-5-카르복실레이트, 가용성 콜라겐, 디부틸프탈레이트 및 겔라틴을 포함한다.Wetting agents that can be used include, but are not limited to, polyhydric alcohols such as glycerol, polyalkylene glycols, and alkylene polyols and mixtures thereof, hyaluronic acid, urea, glycerin, sorbitol, sodium 2-pyrrolidone-5- Carboxylates, soluble collagen, dibutylphthalate and gelatin.
본 발명의 투명한 태양광 차단 조성물은 임의로는 소비자가 조성물을 더 선호하게 하기에 충분한 양의 방향제를 포함할 수 있다. 바람직하게는, 방향제는 조성물의 총 중량을 기준으로 약 0.01% 내지 약 10%의 양으로 존재한다.The transparent sunscreen composition of the present invention may optionally comprise an amount of fragrance sufficient to allow the consumer to prefer the composition. Preferably, the fragrance is present in an amount from about 0.01% to about 10% based on the total weight of the composition.
상기 기재한 태양광 차단 조성물은 자외선의 유해한 영향으로부터 인간의 피부를 보호하기 위한 피부 보호 또는 피부 치료 제품으로서 특히 유용하다. 이러한 태양광 차단 조성물은 눈, 뺨, 턱, 목 및 다른 안면 부위에 도포될 수 있고, 또한 잠재적으로 자외선의 영향을 받을 수 있는 다른 신체 부위에 도포될 수 있다.The sunscreen compositions described above are particularly useful as skin protection or skin treatment products for protecting human skin from the harmful effects of ultraviolet light. Such sunscreen compositions may be applied to the eyes, cheeks, chin, neck and other facial areas, and may also be applied to other body parts that may be potentially affected by ultraviolet light.
본 발명의 태양광 차단 조성물의 사용 방법은 조성물의 목적하는 최종 용도에 의존한다. 예를 들어, 본 발명의 태양광 차단 조성물은 특히 강한 태양광 노출에 대하여 경우에 따른 보호를 위해서 필요에 따라 피부에 도포될 수 있다. 다르게는, 또한 바람직하게는, 태양광 차단 조성물은 규칙적인 방식으로 피부에 도포된다. 예를 들어, 태양광 차단 조성물은 약 1주일에 1회 내지 약 1일 3회의 빈도로 규칙적으로 도포될 수 있다.The method of use of the sunscreen composition of the present invention depends on the desired end use of the composition. For example, the sunscreen composition of the present invention may be applied to the skin as needed for occasional protection against particularly intense sun exposure. Alternatively, also preferably, the sunscreen composition is applied to the skin in a regular manner. For example, the sunscreen composition may be applied regularly at a frequency of about once a week to about three times a day.
하기 실시예는 본 발명의 신규한 조성물 및 방법을 추가적으로 설명하지만, 이에 본 발명이 한정되는 것은 아니다.The following examples further illustrate the novel compositions and methods of the present invention, but the invention is not limited thereto.
실시예 1Example 1
하기 조성물은 에멀젼 겔 형태인 본 발명의 몇 가지 바람직한 실시태양의 예를 제공한다.The following compositions provide examples of some preferred embodiments of the invention in the form of emulsion gels.
조성물 AComposition A
Acid) 90%Rosmarinic acid
Acid) 90%
(로스마리) 추출물Los marinus officialis
(Rothmary) Extract
Heliopan) OSNeo Heliopan
Heliopan) OS
에이트Neopentyl Glycol Diheptano
Eight
조성물 BComposition B
올(ESCALOL) 557Parsol MCX / Escal
All (ESCALOL) 557
90-HPhospholipon
90-H
350FAPoly Pore
350 FA
중합체 페룰산Allyl methacrylate crossover
Polymer ferulic acid
산(Nordihydroguaiaretic
Acid)Nordihydroguaialet
Mountain (Nordihydroguaiaretic
Acid)
산Nordihydroguairaet
mountain
Acid) 90%Rosmarinic acid
Acid) 90%
(로스마리) 추출물Los marinus officialis
(Rothmary) Extract
Heliopan) OSNeo Heliopan
Heliopan) OS
에이트Neopentyl Glycol Diheptano
Eight
Yeast) AELiponyl East
Yeast) AE
물(FAEX)Nylon 6/12 / Yeast Extract
Water (FAEX)
e)Amentoflavon
e)
나(부처손류(Spike Moss))
추출물Selaginella Tamariski
I (Spike Moss)
extract
페닐 비닐 디메티콘 교차중
합체//디페닐시올옥시 페닐
트리메티콘Methyl trimethicone // dimethicone /
Phenyl Vinyl Dimethicone Crossing
Coalescing // diphenylthioloxy phenyl
Trimethicone
스퀴옥산 교차중합체Vinyl dimethicone / methicone
Squioxane Crosspolymer
이트Propylene Glycol Heptanoe
ITE
우 5 B3397)Castor Oil Extract (30% Yellow)
Right 5 B3397)
우 5 B3397)Castor Oil Extract (30% Yellow)
Right 5 B3397)
28 C6529)Castor Oil Extract (30% Red
28 C6529)
28 C6529)Castor Oil Extract (30% Red
28 C6529)
조성물 CComposition C
올(ESCALOL) 557Parsol MCX / Escal
All (ESCALOL) 557
Heliopan) OSNeo Heliopan
Heliopan) OS
에이트Neopentyl Glycol Diheptano
Eight
디메티콘 교차중합체Phenyl trimethicone // dimethicone / phenyl vinyl
Dimethicone Crosspolymer
X-21-5652D
X-21-5652D
페닐 비닐 디메티콘 교차중
합체//디페닐시올옥시 페닐
트리메티콘Methyl trimethicone // dimethicone /
Phenyl Vinyl Dimethicone Crossing
Coalescing // diphenylthioloxy phenyl
Trimethicone
스퀴옥산 교차중합체Vinyl dimethicone / methicone
Squioxane Crosspolymer
이트Propylene Glycol Heptanoe
ITE
우 5 B3397)Castor Oil Extract (30% Yellow)
Right 5 B3397)
우 5 B3397)Castor Oil Extract (30% Yellow)
Right 5 B3397)
28 C6529)Castor Oil Extract (30% Red
28 C6529)
28 C6529)Castor Oil Extract (30% Red
28 C6529)
실시예 2Example 2
하기 실시예는 여러 겔화 물질 (굵은 글씨로 표시함)을 사용한 조성물의 비교 결과를 나타낸다. 모든 성분을 함께 혼합하고 24 시간에 걸쳐 투명도 및 안정성을 관찰하였다.The following examples show the results of a comparison of compositions with various gelling materials (in bold). All components were mixed together and observed for transparency and stability over 24 hours.
Heliopan) OSNeo Heliopan
Heliopan) OS
/페닐 비닐 / Phenyl vinyl
디메티콘Dimethicone
교차중합체 Crosspolymer
페닐 비닐 디메티콘 교차중Phenyl Vinyl Dimethicone Crossing
합체//디페닐시올옥시 페닐 Coalescing // diphenylthioloxy phenyl
트리메티콘Trimethicone
상기 표 1에서 알 수 있는 바와 같이, 본 발명의 디페닐 실리콘 엘라스토머 겔화제 (즉, X-21-5652D 겔화제)를 포함하는 조성물만이 충분한 안정성을 갖고 투명함을 유지하는 조성물이었다. As can be seen in Table 1 above, only the composition comprising the diphenyl silicone elastomer gelling agent (ie, X-21-5652D gelling agent) of the present invention was a composition having sufficient stability and maintaining transparency.
실시예 3Example 3
하기 실시예는 상기 기재한 실시예 2의 기재 조성물 1에서 여러 상이한 용매들을 포함시킨 조성물의 비교 결과를 나타낸다. 각 용매를 실시예 2의 기재 조성물 1에 혼합하고 24 시간에 걸쳐 투명도 및 안정성을 관찰하였다. The following examples show comparison results of compositions comprising several different solvents in Base Composition 1 of Example 2 described above. Each solvent was mixed with the base composition 1 of Example 2 and the transparency and stability were observed over 24 hours.
상기 표 2에서 알 수 있듯이, 특정 용매들만이 안정하고 투명 겔을 제공하며, 다른 용매들은 조성물의 안정성을 저하시키거나 겔 조성물을 형성하지 않았다. As can be seen in Table 2 above, only certain solvents provided a stable and transparent gel, and other solvents did not degrade the stability of the composition or formed a gel composition.
Claims (20)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77811606P | 2006-03-01 | 2006-03-01 | |
US60/778,116 | 2006-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080090557A KR20080090557A (en) | 2008-10-08 |
KR101068276B1 true KR101068276B1 (en) | 2011-09-28 |
Family
ID=38475197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020087021280A Active KR101068276B1 (en) | 2006-03-01 | 2007-02-27 | Transparent sunscreen gel and its use |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1996155A1 (en) |
JP (1) | JP4964253B2 (en) |
KR (1) | KR101068276B1 (en) |
AU (1) | AU2007223713B2 (en) |
CA (1) | CA2642783A1 (en) |
WO (1) | WO2007103654A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100303743A1 (en) * | 2007-09-26 | 2010-12-02 | John Joseph Kennan | Personal Care Compositions Containing Hydrophobic Silicone-Organic Gel Blends |
US8765156B2 (en) | 2009-05-04 | 2014-07-01 | Elc Management Llc | Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound |
WO2010129313A2 (en) | 2009-05-04 | 2010-11-11 | Elc Management Llc | Cosmetic compositions comprising cyanodiphenylacrylates |
AU2012249453B2 (en) * | 2011-04-27 | 2017-03-09 | Isp Investments Inc. | Clear wet sprays and gels |
DE202013103395U1 (en) * | 2013-07-26 | 2013-08-13 | Sasol Germany Gmbh | Transparent sunscreen compositions and their use |
US10066123B2 (en) | 2013-12-09 | 2018-09-04 | 3M Innovative Properties Company | Curable silsesquioxane polymers, compositions, articles, and methods |
US10172783B2 (en) | 2014-06-04 | 2019-01-08 | L'oreal | High UV protection alcohol-free anhydrous clear system |
WO2015195355A1 (en) | 2014-06-20 | 2015-12-23 | 3M Innovative Properties Company | Adhesive compositions comprising a silsesquioxane polymer crosslinker, articles and methods |
WO2015195391A1 (en) | 2014-06-20 | 2015-12-23 | 3M Innovative Properties Company | Adhesive compositions comprising a silsesquioxane polymer crosslinker, articles and methods |
CN106661228A (en) | 2014-06-20 | 2017-05-10 | 3M创新有限公司 | Curable polymers comprising silsesquioxane polymer core and silsesquioxane polymer outer layer and methods |
CN106715538A (en) | 2014-09-22 | 2017-05-24 | 3M创新有限公司 | Curable polymers comprising silsesquioxane polymer core silsesquioxane polymer outer layer, and reactive groups |
US9957416B2 (en) | 2014-09-22 | 2018-05-01 | 3M Innovative Properties Company | Curable end-capped silsesquioxane polymer comprising reactive groups |
WO2016119028A1 (en) * | 2015-01-29 | 2016-08-04 | L'oreal | Transparent sunscreen composition |
US11771630B2 (en) | 2018-08-10 | 2023-10-03 | Shiseido Company, Ltd. | Oil-based cosmetic |
US12083199B2 (en) | 2019-09-10 | 2024-09-10 | LCS Advanced Solutions, LLC | Mineral, anhydrous, broad-spectrum sunscreen |
AU2023251399A1 (en) | 2022-10-15 | 2024-05-02 | Lcs Advanced Solutions | Structurally diverse, stable, and radiation-protective particle matrix sunscreen and cosmetic compositions and related methods |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6045781A (en) | 1998-05-30 | 2000-04-04 | Th. Goldschmidt Ag | Transparent sunscreen gels |
US6290938B1 (en) | 1998-07-30 | 2001-09-18 | The Procter & Gamble Company | Sunscreen compositions |
US6916464B2 (en) | 2002-12-20 | 2005-07-12 | L'oreal | Sunscreen compositions |
US6936241B2 (en) | 2001-08-17 | 2005-08-30 | The Procter & Gamble Company | Sunscreen composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05124945A (en) * | 1991-11-01 | 1993-05-21 | Kao Corp | Ultraviolet ray protecting composition |
FR2715294B1 (en) * | 1994-01-26 | 1996-03-22 | Oreal | Anhydrous cosmetic or dermatological composition containing the combination of a silicone oil and a wax of an ethylene homo- or copolymer. |
DE19707309B4 (en) * | 1997-02-11 | 2004-08-12 | Lancaster Group Gmbh | Solid cosmetic compositions based on solidified oils |
KR100955353B1 (en) * | 2003-03-19 | 2010-04-29 | 가오 가부시키가이샤 | Manufacturing method of cosmetics |
JP4250093B2 (en) * | 2004-01-16 | 2009-04-08 | 日本メナード化粧品株式会社 | Cosmetics |
GB0406037D0 (en) * | 2004-03-18 | 2004-04-21 | Ici Plc | Metal oxide dispersion |
JP2005272389A (en) * | 2004-03-25 | 2005-10-06 | Kose Corp | Oil-in-water type emulsifying cosmetic |
-
2007
- 2007-02-27 JP JP2008557463A patent/JP4964253B2/en active Active
- 2007-02-27 WO PCT/US2007/062846 patent/WO2007103654A1/en active Application Filing
- 2007-02-27 CA CA002642783A patent/CA2642783A1/en not_active Abandoned
- 2007-02-27 KR KR1020087021280A patent/KR101068276B1/en active Active
- 2007-02-27 EP EP07757517A patent/EP1996155A1/en not_active Withdrawn
- 2007-02-27 AU AU2007223713A patent/AU2007223713B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6045781A (en) | 1998-05-30 | 2000-04-04 | Th. Goldschmidt Ag | Transparent sunscreen gels |
US6290938B1 (en) | 1998-07-30 | 2001-09-18 | The Procter & Gamble Company | Sunscreen compositions |
US6936241B2 (en) | 2001-08-17 | 2005-08-30 | The Procter & Gamble Company | Sunscreen composition |
US6916464B2 (en) | 2002-12-20 | 2005-07-12 | L'oreal | Sunscreen compositions |
Also Published As
Publication number | Publication date |
---|---|
JP4964253B2 (en) | 2012-06-27 |
CA2642783A1 (en) | 2007-09-13 |
EP1996155A1 (en) | 2008-12-03 |
KR20080090557A (en) | 2008-10-08 |
AU2007223713A1 (en) | 2007-09-13 |
JP2009528377A (en) | 2009-08-06 |
WO2007103654A1 (en) | 2007-09-13 |
AU2007223713B2 (en) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101068276B1 (en) | Transparent sunscreen gel and its use | |
US20080206172A1 (en) | Clear sunscreen gels and methods of use thereof | |
US20150125403A1 (en) | Personal care and cosmetic compositions comprising renewably-based, biodegradable 1,3-propanediol | |
KR100844036B1 (en) | Cosmetics | |
KR20090100643A (en) | UV-protective cosmetic composition prepared by impregnating foam urethane foam | |
US7144570B2 (en) | Sunscreen compositions and methods of use thereof | |
KR102451738B1 (en) | Cosmetic composition for sunscreen comprising polysaccharide thickener and method for preparing same | |
US11304887B2 (en) | Synergistic photoprotective compositions | |
EP0158412A2 (en) | Sunscreen compositions | |
KR102328636B1 (en) | Topical anhydrous fill formulation for ultraviolet filters | |
JP2014108934A (en) | Ultraviolet absorbent-containing skin external preparation | |
CN112656729A (en) | Oil control isolation composition and preparation method and application thereof | |
KR102354352B1 (en) | Oil-in- water cosmetic composition comprising physical sunscreen | |
JP6865522B2 (en) | Underwater oil type UV protection cosmetics | |
CA2513517A1 (en) | Skin care composition comprising first and second emulsions | |
US20040018219A1 (en) | Cosmetic gel product on the basis of oils and gelling agents | |
JP6445981B2 (en) | Sunscreen composition comprising fatty acid and nonionic linear polymer | |
JP4866066B2 (en) | Cosmetics | |
KR102419912B1 (en) | Mist type sunscreen cosmetic composition | |
EP3614995B1 (en) | Cosmetic composition showing a natural and a healthy-looking appearance | |
EP3727281B1 (en) | Liquid cosmetic with agar shell capsule | |
JPH1149655A (en) | Skin lotion | |
KR102591077B1 (en) | Cosmetic composition | |
JP6995182B1 (en) | Underwater oil type emulsified cosmetic | |
JP3558247B2 (en) | Sunscreen cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0105 | International application |
Patent event date: 20080829 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20080829 Comment text: Request for Examination of Application |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20101014 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20110627 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20110921 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20110921 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20140917 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20140917 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180903 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20180903 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20200901 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20210820 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20220822 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20240903 Start annual number: 14 End annual number: 14 |